- 現金殖利率: 2.79%、總殖利率: 5.16%、5年平均現金配發率: 61.93%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 9.04 | -9.6 | 5.00 | -10.71 | 0.25 | 0 | 55.31 | -1.23 | 2.77 | 0 | 58.08 | 3.71 |
| 2022 (9) | 10.00 | 26.74 | 5.60 | 12.0 | 0.00 | 0 | 56.00 | -11.63 | 0.00 | 0 | 56.00 | -11.63 |
| 2021 (8) | 7.89 | 41.65 | 5.00 | 25.0 | 0.00 | 0 | 63.37 | -11.76 | 0.00 | 0 | 63.37 | -11.76 |
| 2020 (7) | 5.57 | 17.26 | 4.00 | 33.33 | 0.00 | 0 | 71.81 | 13.7 | 0.00 | 0 | 71.81 | 4.96 |
| 2019 (6) | 4.75 | -20.44 | 3.00 | -25.0 | 0.25 | 0 | 63.16 | -5.74 | 5.26 | 0 | 68.42 | 2.12 |
| 2018 (5) | 5.97 | -40.0 | 4.00 | -50.0 | 0.00 | 0 | 67.00 | -16.67 | 0.00 | 0 | 67.00 | -16.67 |
| 2017 (4) | 9.95 | 8.51 | 8.00 | 33.33 | 0.00 | 0 | 80.40 | 22.88 | 0.00 | 0 | 80.40 | 22.88 |
| 2016 (3) | 9.17 | 11.83 | 6.00 | 7.14 | 0.00 | 0 | 65.43 | -4.19 | 0.00 | 0 | 65.43 | -4.19 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 3.05 | 4.81 | 5.17 | 2.36 | 14.56 | 3.06 | 9.12 | 46.62 | 55.63 |
| 24Q2 (19) | 2.91 | -12.35 | 298.63 | 2.06 | -20.77 | 83.93 | 6.22 | 87.35 | 110.14 |
| 24Q1 (18) | 3.32 | -2.06 | 48.88 | 2.60 | -30.48 | 25.6 | 3.32 | -64.07 | 48.88 |
| 23Q4 (17) | 3.39 | 16.9 | 48.03 | 3.74 | 63.32 | 45.53 | 9.24 | 57.68 | -7.88 |
| 23Q3 (16) | 2.90 | 297.26 | -37.23 | 2.29 | 104.46 | -6.91 | 5.86 | 97.97 | -24.29 |
| 23Q2 (15) | 0.73 | -67.26 | -30.48 | 1.12 | -45.89 | 2.75 | 2.96 | 32.74 | -5.13 |
| 23Q1 (14) | 2.23 | -2.62 | 7.73 | 2.07 | -19.46 | 34.42 | 2.23 | -77.77 | 7.73 |
| 22Q4 (13) | 2.29 | -50.43 | -0.87 | 2.57 | 4.47 | 20.09 | 10.03 | 29.59 | 26.8 |
| 22Q3 (12) | 4.62 | 340.0 | 167.05 | 2.46 | 125.69 | 50.0 | 7.74 | 148.08 | 38.21 |
| 22Q2 (11) | 1.05 | -49.28 | -35.19 | 1.09 | -29.22 | -38.76 | 3.12 | 50.72 | -19.38 |
| 22Q1 (10) | 2.07 | -10.39 | -8.0 | 1.54 | -28.04 | -32.46 | 2.07 | -73.83 | -8.0 |
| 21Q4 (9) | 2.31 | 33.53 | -23.0 | 2.14 | 30.49 | -26.21 | 7.91 | 41.25 | 41.5 |
| 21Q3 (8) | 1.73 | 6.79 | 6.79 | 1.64 | -7.87 | 3.8 | 5.60 | 44.7 | 115.38 |
| 21Q2 (7) | 1.62 | -28.0 | 295.12 | 1.78 | -21.93 | 304.55 | 3.87 | 72.0 | 287.0 |
| 21Q1 (6) | 2.25 | -25.0 | 281.36 | 2.28 | -21.38 | 235.29 | 2.25 | -59.75 | 281.36 |
| 20Q4 (5) | 3.00 | 85.19 | 38.25 | 2.90 | 83.54 | 19.34 | 5.59 | 115.0 | 16.95 |
| 20Q3 (4) | 1.62 | 295.12 | 0.0 | 1.58 | 259.09 | 0.0 | 2.60 | 160.0 | 0.0 |
| 20Q2 (3) | 0.41 | -30.51 | 0.0 | 0.44 | -35.29 | 0.0 | 1.00 | 69.49 | 0.0 |
| 20Q1 (2) | 0.59 | -72.81 | 0.0 | 0.68 | -72.02 | 0.0 | 0.59 | -87.66 | 0.0 |
| 19Q4 (1) | 2.17 | 0.0 | 0.0 | 2.43 | 0.0 | 0.0 | 4.78 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 9.52 | 7.98 | 26.15 | 78.62 | 19.41 | 26.16 | N/A | - | ||
| 2024/10 | 8.82 | 12.62 | 16.8 | 69.1 | 18.54 | 23.83 | N/A | - | ||
| 2024/9 | 7.83 | 8.88 | 17.94 | 60.27 | 18.92 | 21.44 | 0.94 | - | ||
| 2024/8 | 7.19 | 11.93 | 10.67 | 52.44 | 19.07 | 20.22 | 1.0 | - | ||
| 2024/7 | 6.42 | -2.9 | 13.6 | 45.25 | 20.61 | 20.02 | 1.01 | - | ||
| 2024/6 | 6.61 | -5.24 | 26.18 | 38.83 | 21.86 | 19.93 | 0.91 | - | ||
| 2024/5 | 6.98 | 10.08 | 30.75 | 32.22 | 21.0 | 19.27 | 0.94 | - | ||
| 2024/4 | 6.34 | 6.5 | 22.44 | 25.24 | 18.56 | 17.74 | 1.02 | - | ||
| 2024/3 | 5.95 | 9.21 | -1.38 | 18.9 | 16.93 | 18.9 | 0.92 | - | ||
| 2024/2 | 5.45 | -27.25 | 8.1 | 12.94 | 27.86 | 20.4 | 0.85 | - | ||
| 2024/1 | 7.49 | 0.46 | 47.45 | 7.49 | 47.45 | 22.5 | 0.77 | - | ||
| 2023/12 | 7.46 | -1.15 | 15.94 | 73.29 | 12.25 | 22.55 | 0.77 | - | ||
| 2023/11 | 7.55 | -0.01 | 9.6 | 65.84 | 11.85 | 21.73 | 0.8 | - | ||
| 2023/10 | 7.55 | 13.72 | 12.29 | 58.29 | 11.99 | 20.68 | 0.84 | - | ||
| 2023/9 | 6.64 | 2.17 | 3.09 | 50.68 | 11.81 | 18.78 | 0.91 | - | ||
| 2023/8 | 6.49 | 14.89 | 4.56 | 44.04 | 13.25 | 17.39 | 0.99 | - | ||
| 2023/7 | 5.65 | 7.85 | 7.82 | 37.52 | 14.82 | 16.23 | 1.06 | - | ||
| 2023/6 | 5.24 | -1.81 | 1.73 | 31.87 | 16.16 | 15.76 | 0.95 | - | ||
| 2023/5 | 5.34 | 3.08 | 20.02 | 26.62 | 19.5 | 16.55 | 0.91 | - | ||
| 2023/4 | 5.18 | -14.22 | 14.44 | 21.29 | 19.42 | 16.26 | 0.92 | - | ||
| 2023/3 | 6.04 | 19.72 | 33.98 | 16.16 | 21.51 | 16.16 | 1.1 | - | ||
| 2023/2 | 5.04 | -0.78 | 32.66 | 10.12 | 15.12 | 16.56 | 1.07 | - | ||
| 2023/1 | 5.08 | -21.01 | 1.76 | 5.08 | 1.76 | 18.4 | 0.97 | - | ||
| 2022/12 | 6.43 | -6.55 | 26.83 | 65.29 | 31.91 | 20.04 | 0.91 | - | ||
| 2022/11 | 6.89 | 2.44 | 39.94 | 58.86 | 32.49 | 20.04 | 0.91 | - | ||
| 2022/10 | 6.72 | 4.41 | 43.88 | 52.05 | 31.67 | 19.37 | 0.94 | - | ||
| 2022/9 | 6.44 | 3.62 | 54.14 | 45.32 | 30.03 | 17.89 | 1.01 | 主要新能源車客戶推出車款受市場熱銷,致使本月營收創新高。 | ||
| 2022/8 | 6.21 | 18.47 | 65.42 | 38.89 | 26.75 | 16.61 | 1.09 | 1.氣候影響美國剷雪車出貨量增2.大陸地區新能源車銷售持續成長,帶動胡連新能源產品持續上升3.新增子公司營收注入效益 | ||
| 2022/7 | 5.24 | 1.76 | 44.1 | 32.67 | 21.32 | 14.84 | 1.21 | - | ||
| 2022/6 | 5.15 | 15.84 | 37.87 | 27.43 | 17.76 | 14.12 | 1.12 | - | ||
| 2022/5 | 4.45 | -1.7 | 11.61 | 22.28 | 13.92 | 13.48 | 1.18 | - | ||
| 2022/4 | 4.52 | 0.42 | 12.98 | 17.82 | 14.46 | 12.83 | 1.24 | - | ||
| 2022/3 | 4.51 | 18.54 | 11.03 | 13.3 | 14.98 | 13.3 | 1.07 | - | ||
| 2022/2 | 3.8 | -23.88 | 19.79 | 8.79 | 17.11 | 13.87 | 1.02 | - | ||
| 2022/1 | 4.99 | -1.55 | 15.15 | 4.99 | 15.15 | 14.99 | 0.95 | - | ||
| 2021/12 | 5.07 | 3.1 | 7.32 | 49.5 | 35.3 | 14.66 | 0.88 | - | ||
| 2021/11 | 4.92 | 5.32 | 16.18 | 44.42 | 39.45 | 13.77 | 0.94 | - | ||
| 2021/10 | 4.67 | 11.85 | 22.25 | 39.53 | 43.05 | 12.6 | 1.03 | - | ||
| 2021/9 | 4.18 | 11.21 | 20.66 | 34.85 | 46.39 | 11.57 | 1.0 | - | ||
| 2021/8 | 3.75 | 3.2 | 25.58 | 30.68 | 50.76 | 11.13 | 1.04 | 去年同期受新冠病毒影響,致同期基期較低 | ||
| 2021/7 | 3.64 | -2.63 | 38.72 | 26.93 | 55.14 | 11.36 | 1.02 | 去年同期受新冠病毒影響,致同期基期較低 | ||
| 2021/6 | 3.74 | -6.21 | 58.5 | 23.29 | 57.87 | 11.73 | 0.84 | 去年同期受新冠病毒影響,致同期基期較低 | ||
| 2021/5 | 3.98 | -0.5 | 74.0 | 19.56 | 57.75 | 12.05 | 0.81 | 去年同期受新冠病毒影響,致同期基期較低 | ||
| 2021/4 | 4.0 | -1.3 | 53.91 | 15.57 | 54.07 | 11.24 | 0.87 | 去年同期受新冠病毒影響,致同期基期較低 | ||
| 2021/3 | 4.06 | 27.89 | 48.78 | 11.57 | 53.35 | 11.57 | 0.74 | 去年同期受新冠病毒影響,致同期基期較低 | ||
| 2021/2 | 3.17 | -26.83 | 72.2 | 7.51 | 55.93 | 12.24 | 0.7 | 去年同期受新冠病毒影響,致同期基期較低 | ||
| 2021/1 | 4.34 | -8.24 | 45.85 | 4.34 | 45.85 | 13.3 | 0.65 | - | ||
| 2020/12 | 4.73 | 11.61 | 14.13 | 36.58 | -3.6 | 12.78 | 0.63 | - | ||
| 2020/11 | 4.23 | 10.82 | 6.67 | 31.85 | -5.78 | 11.52 | 0.7 | - | ||
| 2020/10 | 3.82 | 10.4 | 14.31 | 27.63 | -7.4 | 10.27 | 0.78 | - | ||
| 2020/9 | 3.46 | 15.74 | 1.34 | 23.81 | -10.23 | 9.07 | 0.8 | - | ||
| 2020/8 | 2.99 | 14.0 | -4.59 | 20.35 | -11.94 | 7.97 | 0.91 | - | ||
| 2020/7 | 2.62 | 11.24 | -6.5 | 17.36 | -13.09 | 7.27 | 1.0 | - | ||
| 2020/6 | 2.36 | 2.95 | -13.77 | 14.75 | -14.13 | 7.25 | 0.97 | - | ||
| 2020/5 | 2.29 | -11.99 | -28.7 | 12.4 | -14.2 | 7.62 | 0.92 | - | ||
| 2020/4 | 2.6 | -4.59 | 4.81 | 10.11 | -10.06 | 7.17 | 0.98 | - | ||
| 2020/3 | 2.73 | 48.03 | -24.95 | 7.54 | -14.04 | 7.54 | 1.03 | - | ||
| 2020/2 | 1.84 | -38.03 | -5.18 | 4.82 | -6.32 | 8.96 | 0.87 | - | ||
| 2020/1 | 2.97 | -28.2 | -7.02 | 2.97 | -7.02 | 0.0 | N/A | - | ||
| 2019/12 | 4.14 | 4.31 | 19.15 | 37.95 | -7.02 | 0.0 | N/A | - |
